US pharma industry sees a drop of 22.2% in deal activity in July 2019
The US pharma industry saw a drop of 22.2% in overall deal activity during July 2019, when compared with the last 12-month average, according to GlobalData’s…
Baghmar P
Latest articles
All Articles
Pharma industry M&A deals in Q2 2019 total $114.8bn globally
Total pharma industry M&A deals in Q2 2019 worth $114.8bn were announced globally, according to GlobalData’s deals database. Embed…
Pharma industry venture financing deals in Q2 2019 total $2.72bn in US
Total pharma industry venture financing deals in Q2 2019 worth $2.72bn were announced in the US, according to GlobalData’s…
Pharma industry deals in Q2 2019 total $121.51bn globally
Total pharma industry deals for Q2 2019 worth $121.51bn were announced globally, according to GlobalData’s deals database. Embed this…
Pharma industry private equity deals in Q2 2019 total $2.98bn globally
Total pharma industry private equity deals in Q2 2019 worth $2.98bn were announced globally, according to GlobalData’s deals database.…
Pharma industry venture financing deals in Q2 2019 total $3.72bn globally
Total pharma industry venture financing deals in Q2 2019 worth $3.72bn were announced globally, according to GlobalData’s deals database.…
Pharma industry M&A deals in Q2 2019 total $19.5bn in US
Total pharma industry M&A deals in Q2 2019 worth $19.5bn were announced in the US, according to GlobalData’s deals…
Pharma industry deals in June 2019 total $102.8bn globally
Total pharma industry deals for June 2019 worth $102.8bn were announced globally, according to GlobalData’s deals database. Embed this…
US pharma industry sees a drop of 30.5% in deal activity in June 2019
The US pharma industry saw a drop of 30.5% in overall deal activity during June 2019, when compared with…